<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2021 (5) TMI 1073 - ITAT MUMBAI</title>
    <link>https://www.taxtmi.com/caselaws?id=310010</link>
    <description>The Tribunal allowed the appeals for A.Y. 2016-17 and 2015-16, overturning the disallowance of sales promotion expenses. It directed the A.O to verify and consider the deduction for cess paid. The Tribunal clarified that MCI regulations do not apply to pharmaceutical companies and that the CBDT circular cannot extend these regulations without statutory backing.</description>
    <language>en-us</language>
    <pubDate>Tue, 25 May 2021 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 03 Oct 2023 08:40:44 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=727845" rel="self" type="application/rss+xml"/>
    <item>
      <title>2021 (5) TMI 1073 - ITAT MUMBAI</title>
      <link>https://www.taxtmi.com/caselaws?id=310010</link>
      <description>The Tribunal allowed the appeals for A.Y. 2016-17 and 2015-16, overturning the disallowance of sales promotion expenses. It directed the A.O to verify and consider the deduction for cess paid. The Tribunal clarified that MCI regulations do not apply to pharmaceutical companies and that the CBDT circular cannot extend these regulations without statutory backing.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Tue, 25 May 2021 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=310010</guid>
    </item>
  </channel>
</rss>